Abstract
Background Schizophrenia spectrum disorders (SSD) are associated with cognitive dysfunction, which has been linked to excessive synaptic pruning. To disentangle SSDs genetic vulnerability from secondary effects, we investigated synaptic density in individuals with SSD, unaffected siblings of individuals with SSD, and healthy controls (HC).
Methods We recruited 24 SSD individuals, 25 unaffected siblings, and 26 HC. Participants underwent cognitive assessments using the Brief Assessment of Cognition in Schizophrenia and symptom severity in individuals with SSD was assessed with the Positive and Negative Syndrome Scale. Synaptic density was measured using [11C]UCB-J PET., with binding potential (BPND) calculated across multiple a priori chosen regions of interest (ROIs). Group differences in BPND and associations with cognition and symptoms were assessed using multiple linear regression and correlation.
Results SSD individuals had significant lower cognitive functioning and reduced [11C]UCB-J BPND in frontal, temporal, and limbic regions, including the hippocampus, amygdala, superior temporal gyrus, insula, and inferior frontal gyrus, compared to HC. Siblings exhibited preserved cognitive performance but displayed significant BPND reductions in overlapping regions as SSD individuals, including the hippocampus, amygdala, and superior temporal gyrus, relative to HC. Across all participants, verbal memory performance correlated with BPND in the left superior frontal gyrus, precentral gyrus, and right middle frontal gyrus. Motor speed was associated with BPND in the cerebellum.
Conclusion Despite deficits in synaptic density, siblings maintained intact cognitive performance, suggesting compensatory mechanisms. Our findings support a relationship between synaptic pathology, genetic liability, and cognitive resilience, which may inform targeted interventions for SSD.
Competing Interest Statement
Iris E.C. Sommer received a charity grant from Janssen in 2017, she received speakers fee from Otzuka in 2023 and was active in a trial of Boehringer-Ingelheim from 2021-2025.
Clinical Trial
NL-OMON27759
Funding Statement
ZonMw (Netherlands Organisation for Health Research and Development) [Van der Weijden-Germann] ZonMw (Netherlands Organisation for Health Research and Development) [de Jager] ZonMw (Netherlands Organisation for Health Research and Development) [Nuninga] ZonMw (Netherlands Organisation for Health Research and Development) [de Vries] ZonMw (Netherlands Organisation for Health Research and Development) [van der Weijden] ZonMw (Netherlands Organisation for Health Research and Development) [Sommer]
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The present study protocol was approved by the local medical and ethical committee of the University Medical Centre Groningen.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study may be based available upon request to the authors and ethical approval.
